Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling

Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative

(2018) W.-K. Chan et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Involvement of epithelial-mesenchymal transition in liver fibrosis

(2018) Ning Li et al.   Saudi Journal of Gastroenterology

Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder

(2017) Xiao-Juan Zhao et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis

(2017) Kyle S. McCommis et al.   HEPATOLOGY

Effects of magnesium isoglycyrrhizinate on AST, ALT, and serum levels of Th1 cytokines in patients with allo-HSCT

(2017) Jinglong Lv et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells

(2017) Chunfeng Lu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance

(2017) Neetu Sud et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

A diet-induced Sprague–Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis

(2017) Mayuko Ichimura et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Mechanisms of hepatic stellate cell activation

(2017) Takuma Tsuchida et al.   Nature Reviews Gastroenterology & Hepatology

Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGFβ/Smad and MAPK-JNK Signaling Pathways

(2017) Ji-Hyun Park et al.   Toxins

Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum

(2016) Timothy Hardy et al.   Annual Review of Pathology-Mechanisms of Disease

The protective effect of juglanin on fructose-induced hepatitis by inhibiting inflammation and apoptosis through TLR4 and JAK2/STAT3 signaling pathways in fructose-fed rats

(2016) Guang-Yao Zhou et al.   BIOMEDICINE & PHARMACOTHERAPY

Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT

(2016) K. Wu et al.   CLINICAL SCIENCE

Drug-induced hepatotoxicity in cancer patients - implication for treatment

(2016) Bruno Vincenzi et al.   Expert Opinion On Drug Safety

A micro-RNA expression signature for human NAFLD progression

(2016) Yan Guo et al.   JOURNAL OF GASTROENTEROLOGY

Effects of geniposide on hepatocytes undergoing epithelial–mesenchymal transition in hepatic fibrosis by targeting TGFβ/Smad and ERK-MAPK signaling pathways

(2015) Ji-Hyun Park et al.   BIOCHIMIE

Hepatic inflammation and fibrosis: Functional links and key pathways

(2015) Ekihiro Seki et al.   HEPATOLOGY

Nonalcoholic Fatty Liver Disease

(2015) Mary E. Rinella   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes

(2015) Shuhua Zhao et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Curcumin inhibits cobalt chloride-induced epithelial-to-mesenchymal transition associated with interference with TGF-β/Smad signaling in hepatocytes

(2015) Desong Kong et al.   LABORATORY INVESTIGATION

Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm

(2015) Li-hui Yin et al.   LEUKEMIA RESEARCH

Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function

(2015) Guang-Hua Tang   WORLD JOURNAL OF GASTROENTEROLOGY

Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis

(2014) Michaela Granzow et al.   HEPATOLOGY

A MDM2-dependent positive-feedback loop is involved in inhibition of miR-375 and miR-106b induced byHelicobacter pylorilipopolysaccharide

(2014) Feng Ye et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway

(2014) Xiaolong Tu et al.   JOURNAL OF PATHOLOGY

Molecular mechanisms of epithelial–mesenchymal transition

(2014) Samy Lamouille et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Snail-Regulated MiR-375 Inhibits Migration and Invasion of Gastric Cancer Cells by Targeting JAK2

(2014) Yanjun Xu et al.   PLoS One

FibromiRs: translating molecular discoveries into new anti-fibrotic drugs

(2014) Nicolas Pottier et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study

(2013) Kai Jie Chen et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Dietary fructose in nonalcoholic fatty liver disease

(2013) Miriam B. Vos et al.   HEPATOLOGY

MicroRNAs in liver disease

(2013) Gyongyi Szabo et al.   Nature Reviews Gastroenterology & Hepatology

MicroRNAs in Liver Disease

(2012) Xin Wei Wang et al.   GASTROENTEROLOGY

Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

(2011) Yue-Lei Chen et al.   HEPATOLOGY

TGF-β1 suppresses IL-6-induced STAT3 activation through regulation of Jak2 expression in prostate epithelial cells

(2010) Andrea Staršíchová et al.   CELLULAR SIGNALLING

Fructose at the center of necroinflammation and fibrosis in nonalcoholic steatohepatitis1

(2010) Anna Alisi et al.   HEPATOLOGY

MicroRNAs in Diabetes: Tiny Players in Big Disease

(2009) Amit K. Pandey et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice

(2009) Kojiro Taura et al.   HEPATOLOGY